Utility of Raman Spectroscopy in Pulmonary Medicine.


Journal

Advances in respiratory medicine
ISSN: 2543-6031
Titre abrégé: Adv Respir Med
Pays: Switzerland
ID NLM: 101697329

Informations de publication

Date de publication:
18 Oct 2024
Historique:
received: 01 09 2024
revised: 04 10 2024
accepted: 14 10 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

The Raman effect, or as per its original description, "modified scattering", is an observation that the number of scattered light waves shifts after photons make nonelastic contact with a molecule. This effect allows Raman spectroscopy to be very useful in various fields. Although it is well known that Raman spectroscopy could be very beneficial in medicine as a diagnostic tool, there are not many applications of Raman spectroscopy in pulmonary medicine. Mostly tumor tissue, sputum and saliva have been used as material for analysis in respiratory medicine. Raman spectroscopy has shown promising results in malignancy recognition and even tumor staging. Saliva is a biological fluid that could be used as a reliable biomarker of the physiological state of the human body, and is easily acquired. Saliva analysis using Raman spectroscopy has the potential to be a relatively inexpensive and quick tool that could be used for diagnostic, screening and phenotyping purposes. Chronic obstructive pulmonary disease (COPD) is a growing cause of disability and death, and its phenotyping using saliva analysis via Raman spectroscopy has a great potential to be a dependable tool to, among other things, help reduce hospitalizations and disease burden. Although existing methods are effective and generally available, Raman spectroscopy has the benefit of being quick and noninvasive, potentially reducing healthcare costs and workload.

Identifiants

pubmed: 39452060
pii: arm92050038
doi: 10.3390/arm92050038
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-428

Subventions

Organisme : This research was performed with the frameworks of the ERA PerMED project "Raman analysis of saliva from COPD patients as new biomarker: AI-based point-of-care for the disease monitoring and management (CORSAI)", agreement ES RTD/2022/17
ID : ES RTD/2022/17

Auteurs

Pauls Dzelve (P)

Department of Internal Medicine, Faculty of Medicine, Riga Stradiņš University, LV1007 Riga, Latvia.
Clinical Centre "Gaiļezers", Riga East University Hospital, LV1038 Riga, Latvia.

Arta Legzdiņa (A)

Department of Internal Medicine, Faculty of Medicine, Riga Stradiņš University, LV1007 Riga, Latvia.
Clinical Centre "Gaiļezers", Riga East University Hospital, LV1038 Riga, Latvia.

Andra Krūmiņa (A)

Department of Internal Medicine, Faculty of Medicine, Riga Stradiņš University, LV1007 Riga, Latvia.
Clinical Centre "Gaiļezers", Riga East University Hospital, LV1038 Riga, Latvia.

Madara Tirzīte (M)

Department of Internal Medicine, Faculty of Medicine, Riga Stradiņš University, LV1007 Riga, Latvia.
Clinical Centre "Gaiļezers", Riga East University Hospital, LV1038 Riga, Latvia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH